Janssen’s quarterly schizophrenia drug approved in EUCompany hopes new formulation will improve patient outcomes. Share XJanssen’s quarterly schizophrenia drug approved in EUhttps://pharmaphorum.com/news/janssens-quarterly-schizophrenia-drug-approved-in-eu/